Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer

Area of Science:

• Biotechnology
• Nanomedicine
• Cancer Gene Therapy

Background:

• Efficient delivery of small interfering RNA (siRNA) is crucial for cancer therapy.
• Current delivery systems face challenges in stability and cellular uptake.
• Targeting angiogenesis is a key strategy in cancer treatment.

Purpose of the Study:

• To develop a polyelectrolyte complex (PEC) micelle-based siRNA delivery system for anti-angiogenic gene therapy.
• To evaluate the efficacy and safety of this system in an animal tumor model.
• To investigate the tumor accumulation and biodistribution of the PEC micelles.

Main Methods:

• Formation of nanoscale PEC micelles by complexing poly(ethylene glycol) (PEG)-conjugated vascular endothelial growth factor siRNA (VEGF siRNA-PEG) with polyethylenimine (PEI).
• Administration of VEGF siRNA-PEG/PEI PEC micelles via intravenous and intratumoral routes in an animal tumor model.
• Assessment of VEGF expression, tumor growth inhibition, inflammatory responses, and in vivo optical imaging for micelle distribution.

Main Results:

• The PEC micelles effectively inhibited VEGF expression in tumor tissues.
• Significant suppression of tumor growth was observed following administration of the PEC micelles.
• Enhanced accumulation of PEC micelles in the tumor region was confirmed by in vivo optical imaging.
• No detectable inflammatory responses were observed in mice.

Conclusions:

• Polyelectrolyte complex (PEC) micelles are a feasible and effective carrier for therapeutic siRNAs.
• This system shows potential for both local and systemic treatment of cancer.
• The developed PEC micelle system offers a promising approach for anti-angiogenic gene therapy.